Key EU and UK Regulatory Changes To Watch for in 2026, Life Science Intellectual Property

Partner Jackie Mulryne authored an article outlining the key regulatory changes that the life sciences industry should be watching for in 2026, as the European Union and United Kingdom authorities move to streamline frameworks and accelerate innovation.

Jackie highlights major developments including the EU Pharma Package and offers practical guidance to help companies navigate the shifting regulatory landscape.

Read the full Life Science Intellectual Property article >>
Subscription may be required.